Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsP Wheatley-Price, F Blackhall, S-M Lee, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
British Journal of Cancer|August 31, 2013
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaR Plummer, P Lorigan, E Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaA Gupta, S Love, A Schuh, et al.
British Journal of Cancer|February 18, 2011
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumoursO A Khan, M Gore, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNAG Gremel, R J Lee, M R Girotti, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 4, 2019
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statementH Peach, R Board, M Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trialA Le Cesne, J Y Blay, I Judson, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
British Journal of Cancer|April 29, 2016
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapyS Bowyer, P Prithviraj, P Lorigan, et al.
Pageof 7